Reynders McVeigh Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-1,950
| Closed | -$234K | – | 201 |
|
|
2015
Q2 | $234K | Buy |
+1,950
| New | +$234K | 0.04% | 186 |
|
|
2015
Q1 | – | Sell |
-2,400
| Closed | -$233K | – | 174 |
|
|
2014
Q4 | $233K | Sell |
2,400
-700
| -23% | -$68K | 0.04% | 156 |
|
|
2014
Q3 | $242K | Buy |
+3,100
| New | +$242K | 0.05% | 152 |
|
|
2014
Q2 | – | Sell |
-3,100
| Closed | -$208K | – | 163 |
|
|
2014
Q1 | $208K | Buy |
+3,100
| New | +$208K | 0.05% | 158 |
|